Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
McKesson Corporation stock logo
MCK
McKesson
$1,069.31
+0.7%
$974.65
$723.68
▼
$1,121.50
$123.47B0.27710,413 shs869,451 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
McKesson Corporation stock logo
MCK
McKesson
0.00%-3.08%+5.78%+24.01%+25.15%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
McKesson Corporation stock logo
MCK
McKesson
$1,069.31
+0.7%
$974.65
$723.68
▼
$1,121.50
$123.47B0.27710,413 shs869,451 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
McKesson Corporation stock logo
MCK
McKesson
0.00%-3.08%+5.78%+24.01%+25.15%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
McKesson Corporation stock logo
MCK
McKesson
2.79
Moderate Buy$1,054.12-1.42% Downside

Current Analyst Ratings Breakdown

Latest MCK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetOverweight$1,000.00 ➝ $1,235.00
11/10/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetOverweight$1,042.00 ➝ $1,255.00
11/9/2026
McKesson Corporation stock logo
MCK
McKesson
UpgradeBuy (B) ➝ Buy (B+)
11/5/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetBuy$1,200.00 ➝ $1,250.00
11/5/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetBuy$1,006.00 ➝ $1,200.00
11/5/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetOutperform$1,070.00 ➝ $1,200.00
11/5/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetSector Perform$845.00 ➝ $965.00
10/20/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetNeutral$905.00 ➝ $1,020.00
10/16/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetBuy$1,080.00 ➝ $1,200.00
10/7/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetOutperform$1,030.00 ➝ $1,070.00
(Data available from 11/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
McKesson Corporation stock logo
MCK
McKesson
$418.79B0.29$45.56 per share23.47($31.00) per share-34.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
McKesson Corporation stock logo
MCK
McKesson
$4.76B$38.8927.5020.531.811.12%-202.94%5.92%2/3/2027 (Estimated)

Latest MCK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q2 2027
McKesson Corporation stock logo
MCK
McKesson
$10.72$11.68+$0.96$10.44$109.90 billion$110.96 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
McKesson Corporation stock logo
MCK
McKesson
$3.760.35%+13.68%9.67%17 Years

Latest MCK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/20/2026
McKesson Corporation stock logo
MCK
McKesson
quarterly$0.940.37%12/1/202612/1/20261/4/2027
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
McKesson Corporation stock logo
MCK
McKesson
N/A
0.90
0.52

Institutional Ownership

CompanyInstitutional Ownership
McKesson Corporation stock logo
MCK
McKesson
85.07%

Insider Ownership

CompanyInsider Ownership
McKesson Corporation stock logo
MCK
McKesson
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
McKesson Corporation stock logo
MCK
McKesson
43,000115.46 million115.39 millionOptionable

Recent News About These Companies

McKesson stock broadens healthcare reach with Option Care deal
McKesson (MCK) Dropped, So What Is Driving Attention Now?
McKesson (NYSE:MCK) Stock Gets Price Target Bump from Barclays
Two Deals and a Higher Target: UBS’s Call on McKesson (MCK)
McKesson stock: Barclays raises price target to $1,235
McKesson stock: Barclays lifts target to USD 1,235
The Open Question In McKesson's Two New Deals
The Early Signs Before McKesson Stock's 44% Rise
McKesson stock at EUR 1,001.75, down 0.91% premarket

New MarketBeat Followers Over Time

Media Sentiment Over Time

McKesson stock logo

McKesson NYSE:MCK

$1,069.31 +7.15 (+0.67%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$1,070.08 +0.78 (+0.07%)
As of 11/20/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.